Clinical characteristics of multiple myeloma patients
Patient no. . | Patient age, y/sex . | MM type . | Hgb level, g/L . | WBC count, × 109/L . | Platelets, × 109/L . | Serum paraproteins, g . | Urine paraproteins, g . | Site . |
|---|---|---|---|---|---|---|---|---|
| 1 | 67/M | lgG | 103 | 4.2 | 203 | 6.4 | 0.60 | Bone (diffuse) |
| 2 | 40/F | lgG | 86 | 5 | 49 | 9.3 | 3.40 | (−) bone survey |
| 3 | 57/F | lgG | 102 | 5.3 | 217 | 6.7 | 4.25 | Bone (diffuse) |
| 4 | 50/M | lgA | 111 | 4.9 | 184 | 5.7 | 0.00 | Bone (diffuse) |
| 5 | 52/M | lgG | 121 | 2.9 | 257 | 4.4 | 0.12 | (−) bone survey |
| 6 | 56/F | lgG | 80 | 4 | 33 | 8.4 | 1.68 | (−) bone survey |
| 7 | 63/F | lgG | 100 | 5.5 | 336 | 9.9 | 0.36 | (−) bone survey |
| 8 | 63/M | lgG | 123 | 4.6 | 151 | (−) | 0.02 | Bone (diffuse) |
| 9 | 64/M | lgG | 105 | 4.2 | 219 | 3.5 | 0.01 | T11, clavicle |
| 10 | 35/F | lgA | 91 | 2.6 | 85 | 1.5 | 0.21 | (−) bone survey |
| 11 | 52/M | lgA | 104 | 3.3 | 54 | 0.8 | 17.00 | (−) bone survey |
| 12 | 45/M | lgG | 102 | 11.8 | 338 | 0.1 | 4.273 | Bone (diffuse) |
| 13 | 54/M | lgG | 141 | 4.5 | 262 | 4.7 | 0.00 | (−) bone survey |
| 14 | 66/M | lgA | 102 | 5.9 | 154 | 3.4 | 0.10 | Bone (diffuse) |
| 15 | 50/F | lgG | 119 | 7.1 | 364 | 3.7 | 0.00 | Bone (diffuse) |
| 16 | 40/F | lgG | 103 | 6.2 | 335 | (−) | 0.00 | Skull, apex |
| 17 | 58/M | lgA | 139 | 5.1 | 205 | 4.3 | 0.00 | (−) bone survey |
| 18 | 67/M | lgG | 89 | 8.8 | 52 | 0.4 | 3.90 | (−) bone survey |
| 19 | 56/M | lgG | 133 | 7.8 | 233 | 4.6 | 0.02 | Ribs |
| 20 | 65/M | lgG | 133 | 4.8 | 227 | 2.8 | 0.32 | C2 |
| 21 | 57/M | lgA | 60 | 9.6 | 219 | 3.1 | 4.80 | (−) bone survey |
| 22 | 67/F | lgG | 128 | 5 | 249 | 1.6 | 0.00 | (−) bone survey |
Patient no. . | Patient age, y/sex . | MM type . | Hgb level, g/L . | WBC count, × 109/L . | Platelets, × 109/L . | Serum paraproteins, g . | Urine paraproteins, g . | Site . |
|---|---|---|---|---|---|---|---|---|
| 1 | 67/M | lgG | 103 | 4.2 | 203 | 6.4 | 0.60 | Bone (diffuse) |
| 2 | 40/F | lgG | 86 | 5 | 49 | 9.3 | 3.40 | (−) bone survey |
| 3 | 57/F | lgG | 102 | 5.3 | 217 | 6.7 | 4.25 | Bone (diffuse) |
| 4 | 50/M | lgA | 111 | 4.9 | 184 | 5.7 | 0.00 | Bone (diffuse) |
| 5 | 52/M | lgG | 121 | 2.9 | 257 | 4.4 | 0.12 | (−) bone survey |
| 6 | 56/F | lgG | 80 | 4 | 33 | 8.4 | 1.68 | (−) bone survey |
| 7 | 63/F | lgG | 100 | 5.5 | 336 | 9.9 | 0.36 | (−) bone survey |
| 8 | 63/M | lgG | 123 | 4.6 | 151 | (−) | 0.02 | Bone (diffuse) |
| 9 | 64/M | lgG | 105 | 4.2 | 219 | 3.5 | 0.01 | T11, clavicle |
| 10 | 35/F | lgA | 91 | 2.6 | 85 | 1.5 | 0.21 | (−) bone survey |
| 11 | 52/M | lgA | 104 | 3.3 | 54 | 0.8 | 17.00 | (−) bone survey |
| 12 | 45/M | lgG | 102 | 11.8 | 338 | 0.1 | 4.273 | Bone (diffuse) |
| 13 | 54/M | lgG | 141 | 4.5 | 262 | 4.7 | 0.00 | (−) bone survey |
| 14 | 66/M | lgA | 102 | 5.9 | 154 | 3.4 | 0.10 | Bone (diffuse) |
| 15 | 50/F | lgG | 119 | 7.1 | 364 | 3.7 | 0.00 | Bone (diffuse) |
| 16 | 40/F | lgG | 103 | 6.2 | 335 | (−) | 0.00 | Skull, apex |
| 17 | 58/M | lgA | 139 | 5.1 | 205 | 4.3 | 0.00 | (−) bone survey |
| 18 | 67/M | lgG | 89 | 8.8 | 52 | 0.4 | 3.90 | (−) bone survey |
| 19 | 56/M | lgG | 133 | 7.8 | 233 | 4.6 | 0.02 | Ribs |
| 20 | 65/M | lgG | 133 | 4.8 | 227 | 2.8 | 0.32 | C2 |
| 21 | 57/M | lgA | 60 | 9.6 | 219 | 3.1 | 4.80 | (−) bone survey |
| 22 | 67/F | lgG | 128 | 5 | 249 | 1.6 | 0.00 | (−) bone survey |
MM indicates multiple myeloma; Hgb; hemoglobin; WBC, white blood cell;/F, female;/M, male; and (−), not available.